Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

24 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effects of atorvastatin versus other statins on fasting and postprandial C-reactive protein and lipoprotein-associated phospholipase A2 in patients with coronary heart disease versus control subjects.
Schaefer EJ, McNamara JR, Asztalos BF, Tayler T, Daly JA, Gleason JL, Seman LJ, Ferrari A, Rubenstein JJ. Schaefer EJ, et al. Among authors: rubenstein jj. Am J Cardiol. 2005 May 1;95(9):1025-32. doi: 10.1016/j.amjcard.2005.01.023. Am J Cardiol. 2005. PMID: 15842965
Comparisons of effects of statins (atorvastatin, fluvastatin, lovastatin, pravastatin, and simvastatin) on fasting and postprandial lipoproteins in patients with coronary heart disease versus control subjects.
Schaefer EJ, McNamara JR, Tayler T, Daly JA, Gleason JL, Seman LJ, Ferrari A, Rubenstein JJ. Schaefer EJ, et al. Among authors: rubenstein jj. Am J Cardiol. 2004 Jan 1;93(1):31-9. doi: 10.1016/j.amjcard.2003.09.008. Am J Cardiol. 2004. PMID: 14697462 Clinical Trial.
Comparison of effect of intensive lipid lowering with atorvastatin to less intensive lowering with lovastatin on C-reactive protein in patients with stable angina pectoris and inducible myocardial ischemia.
Kinlay S, Timms T, Clark M, Karam C, Bilodeau T, Ridker PM, Rifai N, Carlson W, Lloyd-Jones DM, Johnstone M, Rubenstein J, Alexander S, Orav J, Stone PH; Vascular Basis Study Group. Kinlay S, et al. Am J Cardiol. 2002 May 15;89(10):1205-7. doi: 10.1016/s0002-9149(02)02306-8. Am J Cardiol. 2002. PMID: 12008177 Clinical Trial. No abstract available.
Effect of intensive lipid lowering, with or without antioxidant vitamins, compared with moderate lipid lowering on myocardial ischemia in patients with stable coronary artery disease: the Vascular Basis for the Treatment of Myocardial Ischemia Study.
Stone PH, Lloyd-Jones DM, Kinlay S, Frei B, Carlson W, Rubenstein J, Andrews TC, Johnstone M, Sopko G, Cole H, Orav J, Selwyn AP, Creager MA; Vascular Basis Study Group. Stone PH, et al. Circulation. 2005 Apr 12;111(14):1747-55. doi: 10.1161/01.CIR.0000160866.90148.76. Epub 2005 Apr 4. Circulation. 2005. PMID: 15809368 Clinical Trial.
24 results